Funder
Health and Family Planning Commission of Sichuan Province
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209–249
2. Lenis AT, Lec PM, Chamie K et al (2020) Bladder Cancer: A Review. JAMA 324(19): 1980
3. Babjuk M, Burger M, Capoun O et al (2022) European Association of Urology Guidelines on non–muscle-invasive bladder Cancer (Ta, T1, and carcinoma in situ). Eur Urol 81(1):75–94
4. Sylvester RJ, van der M A P M, Witjes JA et al (2005) Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174(1):86–91
5. Schmidt S, Kunath F, Coles B et al (2020) Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer. Cochrane Database Syst Rev 1(1):CD011935